V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20022154 | 20088843 | 1.65 | 88.1 | null | 2019-04-21 | 2019-04-21 | Fluorouracil + Folinic + RT Bossett | 02 | N | DOCETAXEL | 100190251 |
| 20022615 | 20088844 | 1.58 | 73.2 | 03 | 2018-05-15 | 2018-05-17 | ACTICCA-1 Trial | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101570575 |
| 20024555 | 20088846 | 1.74 | 71.9 | Palliative (P) | 2016-06-03 | 2016-06-03 | AML 18 TRIAL | 02 | N | ACALABRUTINIB | 101122635 |
| 20029794 | 20088851 | 1.68 | 60.6 | Palliative (P) | 2019-12-13 | 2019-12-31 | ACELARATE Trial | 02 | N | NEO-AEGIS TRIAL | 100507930 |
| 20031339 | 20088852 | 0.7 | 71.45 | 03 | 2018-10-18 | 2018-11-16 | Panitumumab | N | N | CISPLATIN + TEYSUNO | 100842890 |
| 20031973 | 20088854 | 1.73 | 49 | Palliative (P) | 2015-11-15 | 2015-11-27 | Panitumumab | 02 | N | CAP + RT | 101225834 |
| 20032659 | 20088855 | 1.55 | 73.7 | null | 2018-01-27 | 2018-01-28 | Irinotecan 14day | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 101629700 |
| 20033102 | 20088856 | 1.81 | 61.6 | 03 | 2019-06-12 | 2019-06-12 | RUXOLITINIB | 02 | N | MITOMYCIN | 101357756 |
| 20033541 | 20088858 | 1.75 | 77 | 03 | 2017-03-23 | 2017-03-23 | SCOPE 2 TRIAL | 02 | N | PACLITAXEL | 101695090 |
| 20034818 | 20088862 | 1.6 | 80.7 | Palliative (P) | 2019-01-02 | 2019-01-10 | ACTICCA-1 Trial | 01 | N | ERIBULIN | 100774021 |
| 20034897 | 20088863 | 1.66 | 105.3 | Palliative (P) | 2018-10-19 | 2018-11-19 | Doxorubicin + Olaratumab | N | N | EOF | 100677716 |
| 20035408 | 20088865 | 1.7 | 84.9 | 03 | 2019-09-24 | 2019-09-30 | null | null | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100000150 |
| 20035688 | 20088866 | 1.82 | 93.7 | Palliative (P) | 2018-10-25 | 2018-10-26 | EOF | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100982369 |
| 20035904 | 20088867 | 1.76 | 85.8 | 03 | 2019-12-01 | 2019-12-01 | CAP + RT | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100976070 |
| 20036386 | 20088868 | null | 89.3 | Palliative (P) | 2017-03-06 | 2017-03-15 | ACELARATE Trial | 02 | N | STAR TRIAL | 100203970 |
| 20037006 | 20088870 | 1.78 | 85.55 | Palliative (P) | 2017-01-11 | 2017-01-21 | CISPLATIN + FLUOROURACIL + RT | 02 | Y | EVEROLIMUS | 101141852 |
| 20037090 | 20088871 | 1.75 | 53 | Palliative (P) | 2022-01-25 | 2022-02-07 | STAMPEDE TRIAL | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100779563 |
| 20037775 | 20088872 | 1.78 | 73.2 | 03 | 2018-12-20 | 2018-12-22 | PANTHER TRIAL | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101017543 |
| 20038355 | 20088873 | 1.59 | 75.8 | Palliative (P) | 2017-01-06 | 2017-01-09 | null | 02 | N | CISPLATIN + FU + TRASTUZUMAB | 100395340 |
| 20039176 | 20088874 | 1.72 | 59 | 03 | 2018-08-24 | 2018-08-30 | Nilotinib | null | N | CAPITAL TRIAL | 101171699 |
| 20039364 | 20088875 | 1.6 | 60.3 | 03 | 2019-05-27 | 2019-05-27 | DACARBAZINE + DOXORUBICIN | N | N | ECARBOF | 101090148 |
| 20039412 | 20088876 | 1.56 | 66.4 | null | 2018-08-16 | 2018-09-10 | ECarboX | 02 | N | EVEROLIMUS | 101347751 |
| 20039449 | 20088877 | 1.55 | 65 | Palliative (P) | 2018-10-03 | 2018-10-21 | Docetaxel | 02 | N | OXALIPLATIN | 101106231 |
| 20039998 | 20088878 | 1.73 | 75.9 | Palliative (P) | 2019-01-06 | 2019-01-07 | Rituximab | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101839329 |
| 20040304 | 20088879 | 1.75 | 62 | 03 | null | 2018-05-17 | CHOP R | 01 | N | CISPLATIN + PEMETREXED | 100597632 |
| 20040527 | 20088880 | 1.68 | 56.6 | null | 2016-12-15 | 2016-12-16 | Capecitabine + Carboplatin + RT | 02 | N | EVEROLIMUS | 101120597 |
| 20040612 | 20088881 | 1.59 | 93.3 | Palliative (P) | 2017-12-18 | 2017-12-27 | null | 02 | N | TRASTUZUMAB + VINORELBINE | 101227502 |
| 20041438 | 20088882 | 1.51 | null | 03 | 2020-03-12 | 2020-03-19 | ARISTOTLE TRIAL | 01 | N | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 100660835 |
| 20042694 | 20088884 | 1.62 | 86.5 | Palliative (P) | 2017-09-06 | 2017-09-06 | FOXTROT TRIAL | 02 | N | GO2 TRIAL | 100045161 |
| 20044311 | 20088885 | null | null | Palliative (P) | 2019-08-24 | 2019-08-24 | Melphalan IV High dose | N | N | IRINOTECAN | 100223840 |
| 20044417 | 20088886 | 1.82 | 33.2 | 03 | 2019-01-22 | 2019-01-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | OXALIPLATIN | 101641616 |
| 20044980 | 20088887 | 1.79 | 95.15 | 03 | 2019-11-15 | 2019-11-15 | Cape +Cetuximab +Oxalip (3 wk) Load | 02 | N | CAP + RT | 100160694 |
| 20045057 | 20088888 | 1.8 | 78.3 | 03 | 2018-08-29 | 2018-09-02 | CHOP R - 21 days | null | Y | SUNITINIB | 101089226 |
| 20045325 | 20088889 | 1.73 | 81.05 | 03 | 2017-10-01 | 2017-10-11 | Doxorubicin + Olaratumab | 02 | N | ABIRATERONE | 101502837 |
| 20046134 | 20088891 | 1.51 | 58 | 03 | 2017-02-25 | 2017-02-25 | Trabectedin | 01 | N | BORTEZOMIB | 100443890 |
| 20046135 | 20088892 | 1.69 | 88 | 03 | null | 2022-04-22 | Irinotecan | 02 | N | PEMETREXED | 100166988 |
| 20046996 | 20088893 | 1.75 | 70.3 | null | 2019-03-30 | 2019-03-30 | PEMBROLIZUMAB | 02 | N | NEO-AEGIS TRIAL | 100346248 |
| 20048379 | 20088894 | 1.8 | 54.1 | Palliative (P) | null | null | Ralitrexed | 02 | N | CABAZITAXEL | 101181261 |
| 20048711 | 20088895 | 1.6 | 87 | Adjuvant (A) | 2017-08-25 | 2017-08-29 | Capecitabine + Streptozocin | 02 | N | PACIFICO TRIAL | 100796605 |
| 20048721 | 20088896 | 1.82 | 58.7 | Palliative (P) | 2017-08-29 | 2017-09-22 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | CHOP R | 101266698 |
| 20049050 | 20088897 | 1.64 | 50.95 | 03 | 2019-09-12 | 2019-09-26 | Fluorouracil + Streptozocin | 01 | N | GEMCITABINE + PACLITAXEL | 101167184 |
| 20049106 | 20088898 | 1.64 | 0 | 03 | 2018-11-12 | 2018-11-14 | CISPLATIN + RT | 01 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100467613 |
| 20049171 | 20088899 | 1.6 | 43 | null | 2019-11-19 | 2019-11-30 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | PANITUMUMAB | 101155466 |
| 20049933 | 20088900 | 1.67 | 78 | 03 | 2017-11-27 | 2017-11-27 | ESPAC-4 TRIAL | 02 | N | OXALIPLATIN | 100460285 |
| 20051589 | 20088902 | 1.61 | 102 | Palliative (P) | 2020-02-13 | 2020-02-22 | null | null | N | CAP + RT | 100615686 |
| 20051858 | 20088903 | 0 | 0 | null | 2017-06-07 | 2017-06-07 | Capital Trial | 02 | N | DOCETAXEL | 101811196 |
| 20051949 | 20088904 | 1.53 | 58 | Adjuvant (A) | 2020-08-21 | 2020-08-21 | Carboplatin + Vinorelbine IV | 02 | N | ECARBOX | 100930921 |
| 20052510 | 20088905 | 1.73 | 58.6 | 03 | 2017-05-16 | 2017-05-27 | EVEROLIMUS | N | Y | PACLITAXEL | 101230571 |
| 20052634 | 20088906 | 1.64 | 71.4 | Palliative (P) | 2018-09-20 | 2018-09-23 | CARBOPLATIN + GEMCITABINE | 02 | Y | PEMBROLIZUMAB | 100171053 |
| 20053270 | 20088907 | 1.58 | 49.7 | Adjuvant (A) | 2019-03-02 | 2019-03-17 | Gemcitabine+Paclitaxel (Neo-tAnGo) | N | N | ACELARATE TRIAL | 101270416 |